Clinical Trials

GastrointestinalGenitourinaryThoracic

450 enrolled

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07474051 2026-03-16

PERSIST

Enrolling by invitation

178 enrolled

GenitourinaryLymphoidOther hematologic neoplasm

Prostatic Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT05901649 2026-03-13

ArtemisPRO

504 enrolled

Metastatic Hormone-sensitive Prostate Cancer

NCT07309445 2026-03-13

Nova-sTAR

150 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06334120 2026-03-12

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

600 enrolled

Non-metastatic Castration-resistant Prostate Cancer

NCT07454603 2026-03-06

PROSTest_STRAT

1,500 enrolled

Disease, Prostatic Neoplasms

NCT07455058 2026-03-06

VAPOR-LTR

2,500 enrolled

Prostatic Neoplasms

NCT07290270 2026-03-05

PSMAreal

170 enrolled

Prostatic Neoplasms

NCT02184416 2026-02-27

ADONIS

554 enrolled

Carcinoma, Renal Cell

NCT03647878 2026-02-27

CABOCARE

224 enrolled

Carcinoma, Renal Cell

NCT04106349 2026-02-27

REPLICA

150 enrolled

Carcinoma, Renal Cell

NCT05858749 2026-02-27

A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).

494 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT05968599 2026-02-25

A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

2,731 enrolled 14 charts

Prostatic Neoplasms, Castration-Resistant

NCT04122976 2026-02-24

DAROL

805 enrolled

Prostatic Neoplasms

NCT06412848 2026-02-24

JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study

360 enrolled

Carcinoma, Transitional Cell

NCT07038928 2026-02-24

RIVERS

600 enrolled

Urinary Bladder Neoplasms

NCT07052578 2026-02-24

CONCORD

400 enrolled

Prostatic Neoplasms

NCT07124000 2026-02-24

DP-04

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

100 enrolled

Adenocarcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Melanoma, Mouth Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gastrointestinal Stromal Tumors, Small Cell Lung Carcinoma

NCT06026332 2026-02-17

ABLE-41

Terminated

202 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT04981119 2026-02-13

BASECAMP-1

BreastGastrointestinalGenitourinaryGynecologicOther solid neoplasmThoracic

200 enrolled

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT07406282 2026-02-12

Double-DARE

1,400 enrolled

Prostatic Neoplasms

NCT07386847 2026-02-04

A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer

3,000 enrolled

Carcinoma, Transitional Cell

NCT04964271 2026-02-02

Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants

60 enrolled

Prostatic Neoplasms

NCT05701007 2026-01-29

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

1,083 enrolled 29 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT07344779 2026-01-26

ROAD

1,600 enrolled

Prostatic Neoplasms

NCT03516110 2026-01-23

PRISME

831 enrolled

Prostatic Neoplasms

NCT05366881 2026-01-20

CAMPERR

BreastCNSGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmPlasma cellSarcomaThoracic

7,000 enrolled

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06010914 2026-01-16

DADOX

100 enrolled

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT03782207 2026-01-08

IMreal

GastrointestinalGenitourinaryThoracic

2,756 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Small Cell Lung Carcinoma

NCT07327489 2026-01-08

ELEPHAS-05

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

2,000 enrolled

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06870253 2026-01-06

Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases

80 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria

NCT06717295 2026-01-02

CCANED-CIPHER

CNSGastrointestinalGenitourinaryGynecologicThoracic

6,000 enrolled

Pancreatic cancer, adult, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06072196 2025-12-31

A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

3,017 enrolled 5 charts

Prostatic Neoplasms

NCT06514521 2025-12-30

Post Marketing Study on Pluvicto in Korea

278 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT06517719 2025-12-30

Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer

500 enrolled

Prostatic Neoplasms

NCT05520099 2025-12-26

ELEPHAS-02